Daré Bioscience (122) Stock Statistics & Valuation Metrics

Daré Bioscience has a market cap or net worth of €27.61M. The enterprise value is €9.90M.

Daré Bioscience has ― shares outstanding. The number of shares has decreased by -2.65% in one year.

Daré Bioscience’s return on equity (ROE) is -4.71 and return on invested capital (ROIC) is -124.50%.

The current PE Ratio of Daré Bioscience is ―. Daré Bioscience’s PEG ratio is -0.11.

In the last 12 months, Daré Bioscience had revenue of 1.03M and earned -13.40M in profits. Earnings per share was -1.20.

In the last 12 months, operating cash flow was -9.94M and capital expenditures -227.95K, giving a free cash flow of -10.16M billion.

Daré Bioscience pays an annual dividend of ―, resulting in a dividend yield of ―

Daré Bioscience upcoming earnings date is Aug 6, 2026, TBA (Confirmed).

Daré Bioscience as a current ratio of 1.14, with Debt / Equity ratio of 978.02%

In the past 12 months, Daré Bioscience has paid 0.00 in taxes.

Daré Bioscience EV to EBITDA ratio is -16.99, with an EV/FCF ratio of -0.02.

Daré Bioscience has €18.52M in cash and marketable securities with €7.18M in debt, giving a net cash position of €11.34M billion.

Gross margin is 5.57%, with operating margin of -1315.51%, and net profit margin of -1300.66%.

The average price target for Daré Bioscience is €8.61, which is 11.43% higher than the current price. The consensus rating is Moderate Buy